Besides, relative expression of EMT markers in the tumor enriched ACT1lowCD68+ macrophages of CRC patients further suggested that ACT1 knockdown in macrophages involved in adenoma-adenocarcinoma transition. The gene discussed is TRAF3IP2; the disease is adenoma.